<img height="1" width="1" src="https://www.facebook.com/tr?id=841180246705289&amp;ev=PageView &amp;noscript=1">

We measure our impact by patient outcomes and the success of our partners. Learn More 

Dascena begins a sepsis randomized clinical trial

December 1, 2016

Dascena has initiated a randomized controlled trial at UCSF Medical Center to evaluate the effects of InSight, a machine learning-based sepsis prediction algorithm. The algorithm will monitor adult ICU patients randomly assigned to the experimental group, and patient outcomes in this group will be compared to those in the control group.

See more details here. ClinicalTrials.gov identifier: NCT03015454

Interested in learning more?

Proud sponsor of Sepsis Alliance